vs
Side-by-side financial comparison of ASGN Inc (ASGN) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
ASGN Inc is the larger business by last-quarter revenue ($970.0M vs $493.8M, roughly 2.0× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 0.6%, a 6.3% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -3.0%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -3.2%).
ASGN Inc is a leading U.S.-headquartered professional services and workforce solutions provider. It specializes in supplying skilled talent and consulting services across high-growth segments including information technology, creative, digital, life sciences, and engineering, primarily serving enterprise clients across North America.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
ASGN vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $970.0M | $493.8M |
| Net Profit | $5.5M | $33.7M |
| Gross Margin | 27.5% | — |
| Operating Margin | 2.9% | 9.9% |
| Net Margin | 0.6% | 6.8% |
| Revenue YoY | -3.0% | -1.7% |
| Net Profit YoY | -73.7% | 10.5% |
| EPS (diluted) | $0.13 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $970.0M | — | ||
| Q4 25 | $980.1M | $493.8M | ||
| Q3 25 | $1.0B | $492.9M | ||
| Q2 25 | $1.0B | $468.8M | ||
| Q1 25 | $968.3M | $458.4M | ||
| Q4 24 | $985.0M | $502.4M | ||
| Q3 24 | $1.0B | $511.2M | ||
| Q2 24 | $1.0B | $504.3M |
| Q1 26 | $5.5M | — | ||
| Q4 25 | $25.2M | $33.7M | ||
| Q3 25 | $38.1M | $71.7M | ||
| Q2 25 | $29.3M | $39.3M | ||
| Q1 25 | $20.9M | $20.7M | ||
| Q4 24 | $42.4M | $30.5M | ||
| Q3 24 | $47.5M | $19.4M | ||
| Q2 24 | $47.2M | $-153.0M |
| Q1 26 | 27.5% | — | ||
| Q4 25 | 28.9% | — | ||
| Q3 25 | 29.4% | — | ||
| Q2 25 | 28.7% | — | ||
| Q1 25 | 28.4% | — | ||
| Q4 24 | 29.0% | — | ||
| Q3 24 | 29.1% | — | ||
| Q2 24 | 29.1% | — |
| Q1 26 | 2.9% | — | ||
| Q4 25 | 5.7% | 9.9% | ||
| Q3 25 | 6.7% | 13.8% | ||
| Q2 25 | 5.8% | 12.8% | ||
| Q1 25 | 4.8% | 7.0% | ||
| Q4 24 | 7.5% | 7.8% | ||
| Q3 24 | 7.7% | 6.6% | ||
| Q2 24 | 7.8% | -31.3% |
| Q1 26 | 0.6% | — | ||
| Q4 25 | 2.6% | 6.8% | ||
| Q3 25 | 3.8% | 14.5% | ||
| Q2 25 | 2.9% | 8.4% | ||
| Q1 25 | 2.2% | 4.5% | ||
| Q4 24 | 4.3% | 6.1% | ||
| Q3 24 | 4.6% | 3.8% | ||
| Q2 24 | 4.6% | -30.3% |
| Q1 26 | $0.13 | — | ||
| Q4 25 | $0.58 | $0.40 | ||
| Q3 25 | $0.87 | $0.84 | ||
| Q2 25 | $0.67 | $0.46 | ||
| Q1 25 | $0.48 | $0.24 | ||
| Q4 24 | $0.94 | $0.37 | ||
| Q3 24 | $1.06 | $0.23 | ||
| Q2 24 | $1.02 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $143.6M | $375.2M |
| Total DebtLower is stronger | $1.5B | $570.5M |
| Stockholders' EquityBook value | $1.8B | $865.9M |
| Total Assets | $4.0B | $2.2B |
| Debt / EquityLower = less leverage | 0.82× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $143.6M | — | ||
| Q4 25 | $161.2M | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | $205.2M | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M |
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.2B | $570.5M | ||
| Q3 25 | $1.2B | $577.2M | ||
| Q2 25 | $1.2B | $583.9M | ||
| Q1 25 | $1.3B | $590.5M | ||
| Q4 24 | $1.0B | $597.1M | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $1.0B | — |
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $865.9M | ||
| Q3 25 | $1.8B | $890.7M | ||
| Q2 25 | $1.8B | $833.8M | ||
| Q1 25 | $1.8B | $789.2M | ||
| Q4 24 | $1.8B | $764.9M | ||
| Q3 24 | $1.8B | $732.5M | ||
| Q2 24 | $1.8B | $706.5M |
| Q1 26 | $4.0B | — | ||
| Q4 25 | $3.7B | $2.2B | ||
| Q3 25 | $3.7B | $2.2B | ||
| Q2 25 | $3.7B | $2.1B | ||
| Q1 25 | $3.7B | $2.0B | ||
| Q4 24 | $3.4B | $2.2B | ||
| Q3 24 | $3.4B | $2.1B | ||
| Q2 24 | $3.5B | $2.0B |
| Q1 26 | 0.82× | — | ||
| Q4 25 | 0.65× | 0.66× | ||
| Q3 25 | 0.64× | 0.65× | ||
| Q2 25 | 0.66× | 0.70× | ||
| Q1 25 | 0.72× | 0.75× | ||
| Q4 24 | 0.58× | 0.78× | ||
| Q3 24 | 0.58× | — | ||
| Q2 24 | 0.57× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $114.1M |
| Free Cash FlowOCF − Capex | $9.1M | — |
| FCF MarginFCF / Revenue | 0.9% | — |
| Capex IntensityCapex / Revenue | 1.0% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $290.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $102.3M | $114.1M | ||
| Q3 25 | $83.9M | $137.3M | ||
| Q2 25 | $124.9M | $137.2M | ||
| Q1 25 | $16.8M | $-117.5M | ||
| Q4 24 | $100.2M | $133.0M | ||
| Q3 24 | $135.8M | $91.8M | ||
| Q2 24 | $90.7M | $107.0M |
| Q1 26 | $9.1M | — | ||
| Q4 25 | $93.7M | — | ||
| Q3 25 | $72.0M | — | ||
| Q2 25 | $115.8M | — | ||
| Q1 25 | $6.6M | — | ||
| Q4 24 | $88.9M | — | ||
| Q3 24 | $127.9M | — | ||
| Q2 24 | $85.4M | — |
| Q1 26 | 0.9% | — | ||
| Q4 25 | 9.6% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 11.3% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 12.4% | — | ||
| Q2 24 | 8.3% | — |
| Q1 26 | 1.0% | — | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.06× | 3.39× | ||
| Q3 25 | 2.20× | 1.91× | ||
| Q2 25 | 4.26× | 3.49× | ||
| Q1 25 | 0.80× | -5.66× | ||
| Q4 24 | 2.36× | 4.36× | ||
| Q3 24 | 2.86× | 4.72× | ||
| Q2 24 | 1.92× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASGN
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
